{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T21:19:24Z","timestamp":1793740764861,"version":"4.6.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T00:00:00Z","timestamp":1721260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T00:00:00Z","timestamp":1721260800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Fundamental Research Funds for the Central Universities of Central South University","award":["512340072"],"award-info":[{"award-number":["512340072"]}],"id":[{"id":"https:\/\/ror.org\/00f1zfq44","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81500359"],"award-info":[{"award-number":["81500359"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Research project of Hunan Provincial Health Commission","award":["20200768"],"award-info":[{"award-number":["20200768"]}]},{"name":"Chinese Cardiovascular Association- Access fund","award":["grant No. 2020-CCA-ACCESS-115"],"award-info":[{"award-number":["grant No. 2020-CCA-ACCESS-115"]}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"crossref","award":["2016JJ4100"],"award-info":[{"award-number":["2016JJ4100"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The relationship between the triglyceride-glucose (TyG) index and its derived index, the triglyceride glucose-waist height ratio (TyG-WHtR), with mortality and cardiovascular diseases (CVDs) in patients with non-alcoholic fatty liver disease (NAFLD) remains unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This study enrolled 6627 adults aged 18 and above diagnosed NAFLD from the National Health and Nutrition Examination Survey (NHANES, 1999\u20132018). Binary weighted logistic regression analyses, cox proportional hazards model and restricted cubic spline (RCS) were used to analyze the relationship between TyG and TyG-WHtR with all-cause mortality, CVD mortality and CVDs. Mediation analysis explored the mediating role of glycohemoglobin, insulin and hypertension in the above relationships. Meanwhile, the incremental predictive value of the TyG index and TyG-WHtR was further assessed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Except for no significant association between the TyG index and both all-cause mortality and chronic heart failure (CHF), both TyG and TyG-WHtR exhibited significant positive correlations or trends of positive correlation with all-cause mortality, CVD mortality, total-CVD, CHF, coronary heart disease (CHD) and angina pectoris. For all-cause mortality, CVD mortality and CHF, TyG-WHtR was a better predictor than TyG (TyG-WHtR: HR 1.31, 95%CI 1.03\u20131.66; HR 2.22, 95%CI 1.42\u20133.47; OR 3.99, 95%CI 1.79\u20138.93). In contrast, TyG index demonstrated a stronger association with total-CVD, CHD and angina pectoris (TyG index: OR 2.00, 95%CI 1.26\u20133.18; OR 1.85, 95%CI 1.19\u20132.91; OR 2.93, 95%CI 1.23-7.00). RCS analysis showed that after adjusting for covariates, most of the aforementioned relationships were linear(P overall\u2009&lt;\u20090.0001, P-nonlinear\u2009&gt;\u20090.05), while the associations of the TyG index and TyG-WHtR with all-cause mortality and CHF were non-linear(P overall\u2009&lt;\u20090.0001, P nonlinear\u2009&lt;\u20090.05). The addition of the TyG index and TyG-WHtR to the basic model for outcomes improved the C-statistics, net reclassification improvement value, and integrated discrimination improvement value.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The predictive value of TyG or TyG-WHtR for all-cause mortality and cardiovascular risk in NAFLD patients was significant. The TyG index and TyG-WHtR might be valid predictors of cardiovascular outcomes of patients with NAFLD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12933-024-02354-4","type":"journal-article","created":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T12:03:00Z","timestamp":1721304180000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":126,"title":["Association of triglyceride glucose-related parameters with all-cause mortality and cardiovascular disease in NAFLD patients: NHANES 1999\u20132018"],"prefix":"10.1186","volume":"23","author":[{"given":"Yusha","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengjiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianjun","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaqin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,18]]},"reference":[{"issue":"9","key":"2354_CR1","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1093\/cvr\/cvad095","volume":"119","author":"C Grander","year":"2023","unstructured":"Grander C, Grabherr F, Tilg H. Non-alcoholic fatty liver disease: pathophysiological concepts and treatment options. [Cardiovasc Res. 2023;119(9):1787\u201398.","journal-title":"[Cardiovasc Res"},{"issue":"9","key":"2354_CR2","first-page":"1691","volume":"69","author":"G Targher","year":"2020","unstructured":"Targher G, Byrne CD, Tilg H. NAFLD and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and pharmacological implications. [Gut. 2020;69(9):1691\u2013705.","journal-title":"[Gut"},{"issue":"1","key":"2354_CR3","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/BF01228309","volume":"18","author":"H Keen","year":"1980","unstructured":"Keen H, Jarrett RJ, Alberti KG. Diabetes mellitus: a new look at diagnostic criteria. [Diabetologia. 1980;18(1):81.","journal-title":"[Diabetologia"},{"key":"2354_CR4","first-page":"i2416","volume":"353","author":"JA Damen","year":"2016","unstructured":"Damen JA, Hooft L, Schuit E, et al. Prediction models for cardiovascular disease risk in the general population. Syst review[Bmj. 2016;353:i2416.","journal-title":"Syst review[Bmj"},{"issue":"1","key":"2354_CR5","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12933-023-02115-9","volume":"23","author":"K Dang","year":"2024","unstructured":"Dang K, Wang X, Hu J, et al. The association between triglyceride-glucose index and its combination with obesity indicators and cardiovascular disease: NHANES 2003\u20132018[. Cardiovasc Diabetol. 2024;23(1):8.","journal-title":"Cardiovasc Diabetol"},{"issue":"3","key":"2354_CR6","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1161\/CIRCHEARTFAILURE.112.000022","volume":"6","author":"D Banerjee","year":"2013","unstructured":"Banerjee D, Biggs ML, Mercer L, et al. Insulin resistance and risk of incident heart failure. Cardiovasc Health Study[Circ Heart Fail. 2013;6(3):364\u201370.","journal-title":"Cardiovasc Health Study[Circ Heart Fail"},{"issue":"1","key":"2354_CR7","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12933-019-0982-2","volume":"19","author":"J Alizargar","year":"2020","unstructured":"Alizargar J, Bai CH, Hsieh NC, et al. Use of the triglyceride-glucose index (TyG) in cardiovascular disease patients. [Cardiovasc Diabetol. 2020;19(1):8.","journal-title":"[Cardiovasc Diabetol"},{"issue":"3","key":"2354_CR8","doi-asserted-by":"publisher","first-page":"e0149731","DOI":"10.1371\/journal.pone.0149731","volume":"11","author":"LK Er","year":"2016","unstructured":"Er LK, Wu S, Chou HH, et al. Triglyceride glucose-body Mass Index is a simple and clinically useful surrogate marker for insulin resistance in nondiabetic Individuals[. PLoS ONE. 2016;11(3):e0149731.","journal-title":"PLoS ONE"},{"issue":"1","key":"2354_CR9","first-page":"123","volume":"21","author":"J Zhao","year":"2022","unstructured":"Zhao J, Fan H, Wang T, et al. TyG index is positively associated with risk of CHD and coronary atherosclerosis severity among NAFLD. patients[Cardiovasc Diabetol. 2022;21(1):123.","journal-title":"patients[Cardiovasc Diabetol"},{"issue":"1","key":"2354_CR10","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s12933-022-01511-x","volume":"21","author":"LC Tao","year":"2022","unstructured":"Tao LC, Xu JN, Wang TT, et al. Triglyceride-glucose index as a marker in cardiovascular diseases: landscape and limitations[. Cardiovasc Diabetol. 2022;21(1):68.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2354_CR11","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s12933-022-01507-7","volume":"21","author":"R Huang","year":"2022","unstructured":"Huang R, Wang Z, Chen J, et al. Prognostic value of triglyceride glucose (TyG) index in patients with acute decompensated heart failure. [Cardiovasc Diabetol. 2022;21(1):88.","journal-title":"[Cardiovasc Diabetol"},{"issue":"9771","key":"2354_CR12","first-page":"1085","volume":"377","author":"D Wormser","year":"2011","unstructured":"Wormser D, Kaptoge S, Di Angelantonio E, et al. Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies. [Lancet. 2011;377(9771):1085\u201395.","journal-title":"[Lancet"},{"issue":"9787","key":"2354_CR13","first-page":"226","volume":"378","author":"S Yusuf","year":"2011","unstructured":"Yusuf S, Anand S. Body-mass index, abdominal adiposity, and cardiovascular. risk[Lancet. 2011;378(9787):226\u20137. author reply 228.","journal-title":"risk[Lancet"},{"issue":"1","key":"2354_CR14","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1186\/s12933-022-01729-9","volume":"21","author":"X Tian","year":"2022","unstructured":"Tian X, Chen S, Wang P, et al. Insulin resistance mediates obesity-related risk of cardiovascular disease: a prospective cohort study. [Cardiovasc Diabetol. 2022;21(1):289.","journal-title":"[Cardiovasc Diabetol"},{"key":"2354_CR15","first-page":"m3324","volume":"370","author":"A Jayedi","year":"2020","unstructured":"Jayedi A, Soltani S, Zargar MS, et al. Central fatness and risk of all cause mortality: systematic review and dose-response meta-analysis of 72 prospective cohort studies. [Bmj. 2020;370:m3324.","journal-title":"[Bmj"},{"issue":"1","key":"2354_CR16","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s12944-021-01561-2","volume":"20","author":"G Sheng","year":"2021","unstructured":"Sheng G, Lu S, Xie Q, et al. The usefulness of obesity and lipid-related indices to predict the presence of non-alcoholic fatty liver disease[. Lipids Health Dis. 2021;20(1):134.","journal-title":"Lipids Health Dis"},{"issue":"3","key":"2354_CR17","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1007\/s12020-021-02815-w","volume":"74","author":"M Malek","year":"2021","unstructured":"Malek M, Khamseh ME, Chehrehgosha H, et al. Triglyceride glucose-waist to height ratio: a novel and effective marker for identifying hepatic steatosis in individuals with type 2 diabetes mellitus. [Endocrine. 2021;74(3):538\u201345.","journal-title":"[Endocrine"},{"key":"2354_CR18","doi-asserted-by":"publisher","first-page":"862919","DOI":"10.3389\/fendo.2022.862919","volume":"13","author":"X Li","year":"2022","unstructured":"Li X, Sun M, Yang Y, et al. Predictive effect of triglyceride glucose-related parameters, obesity indices, and lipid ratios for diabetes in a Chinese Population: a prospective cohort Study[. Front Endocrinol (Lausanne). 2022;13:862919.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2354_CR19","doi-asserted-by":"publisher","first-page":"949831","DOI":"10.3389\/fendo.2022.949831","volume":"13","author":"W Xuan","year":"2022","unstructured":"Xuan W, Liu D, Zhong J, et al. Impacts of triglyceride glucose-Waist to height ratio on diabetes incidence: a secondary analysis of a Population-based Longitudinal Data[. Front Endocrinol (Lausanne). 2022;13:949831.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"2354_CR20","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/apt.13012","volume":"41","author":"CE Ruhl","year":"2015","unstructured":"Ruhl CE, Everhart JE. Fatty liver indices in the multiethnic United States National Health and Nutrition Examination Survey[. Aliment Pharmacol Ther. 2015;41(1):65\u201376.","journal-title":"Aliment Pharmacol Ther"},{"key":"2354_CR21","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s12933-014-0146-3","volume":"13","author":"T Du","year":"2014","unstructured":"Du T, Yuan G, Zhang M, et al. Clinical usefulness of lipid ratios, visceral adiposity indicators, and the triglycerides and glucose index as risk markers of insulin resistance[. Cardiovasc Diabetol. 2014;13:146.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2354_CR22","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1186\/s12933-023-02030-z","volume":"22","author":"Q Zhang","year":"2023","unstructured":"Zhang Q, Xiao S, Jiao X, et al. The triglyceride-glucose index is a predictor for cardiovascular and all-cause mortality in CVD patients with diabetes or pre-diabetes: evidence from NHANES 2001\u20132018[. Cardiovasc Diabetol. 2023;22(1):279.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2354_CR23","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/s12933-022-01606-5","volume":"21","author":"X Wang","year":"2022","unstructured":"Wang X, Xu W, Song Q, et al. Association between the triglyceride-glucose index and severity of coronary artery disease. [Cardiovasc Diabetol. 2022;21(1):168.","journal-title":"[Cardiovasc Diabetol"},{"issue":"1","key":"2354_CR24","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1186\/s12933-023-02001-4","volume":"22","author":"Q Zhou","year":"2023","unstructured":"Zhou Q, Yang J, Tang H, et al. High triglyceride-glucose (TyG) index is associated with poor prognosis of heart failure with preserved ejection fraction. [Cardiovasc Diabetol. 2023;22(1):263.","journal-title":"[Cardiovasc Diabetol"},{"issue":"1","key":"2354_CR25","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/s12933-020-01121-5","volume":"19","author":"N Barzegar","year":"2020","unstructured":"Barzegar N, Tohidi M, Hasheminia M, et al. The impact of triglyceride-glucose index on incident cardiovascular events during 16 years of follow-up: Tehran lipid and glucose study. Cardiovasc Diabetol. 2020;19(1):155.","journal-title":"Cardiovasc Diabetol"},{"issue":"7285","key":"2354_CR26","first-page":"785","volume":"1","author":"PJ Randle","year":"1963","unstructured":"Randle PJ, Garland PB, Hales CN, et al. The glucose fatty-acid cycle. Its role Insulin Sensit Metabolic Disturbances Diabetes mellitus[Lancet. 1963;1(7285):785\u20139.","journal-title":"Its role Insulin Sensit Metabolic Disturbances Diabetes mellitus[Lancet"},{"issue":"1","key":"2354_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1172\/JCI92035","volume":"127","author":"AR Saltiel","year":"2017","unstructured":"Saltiel AR, Olefsky JM. Inflammatory mechanisms linking obesity and metabolic disease[. J Clin Invest. 2017;127(1):1\u20134.","journal-title":"J Clin Invest"},{"issue":"12","key":"2354_CR28","first-page":"1596","volume":"3","author":"H Tilg","year":"2021","unstructured":"Tilg H, Adolph TE, Dudek M, et al. Non-alcoholic fatty liver disease: the interplay between metabolism. Microbes immunity[Nat Metab. 2021;3(12):1596\u2013607.","journal-title":"Microbes immunity[Nat Metab"},{"key":"2354_CR29","doi-asserted-by":"crossref","unstructured":"Tana C, Ballestri S, Ricci F et al. Cardiovascular Risk in non-alcoholic fatty liver disease: mechanisms and therapeutic Implications[. Int J Environ Res Public Health 2019;16(17).","DOI":"10.3390\/ijerph16173104"},{"issue":"2","key":"2354_CR30","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.jhep.2016.09.022","volume":"66","author":"J Ma","year":"2017","unstructured":"Ma J, Hwang SJ, Pedley A, et al. Bi-directional analysis between fatty liver and cardiovascular disease risk factors[. J Hepatol. 2017;66(2):390\u20137.","journal-title":"J Hepatol"},{"issue":"15","key":"2354_CR31","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1161\/CIRCULATIONAHA.105.563213","volume":"113","author":"JA Kim","year":"2006","unstructured":"Kim JA, Montagnani M, Koh KK, et al. Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms. [Circulation. 2006;113(15):1888\u2013904.","journal-title":"[Circulation"},{"issue":"2","key":"2354_CR32","doi-asserted-by":"publisher","first-page":"H813","DOI":"10.1152\/ajpheart.00092.2005","volume":"289","author":"MA Potenza","year":"2005","unstructured":"Potenza MA, Marasciulo FL, Chieppa DM, et al. Insulin resistance in spontaneously hypertensive rats is associated with endothelial dysfunction characterized by imbalance between NO and ET-1 production[. Am J Physiol Heart Circ Physiol. 2005;289(2):H813\u2013822.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"4","key":"2354_CR33","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1111\/j.1572-0241.2005.41500.x","volume":"100","author":"Z Yesilova","year":"2005","unstructured":"Yesilova Z, Yaman H, Oktenli C, et al. Systemic markers of lipid peroxidation and antioxidants in patients with nonalcoholic fatty liver disease[. Am J Gastroenterol. 2005;100(4):850\u20135.","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"2354_CR34","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1093\/clinchem\/47.5.887","volume":"47","author":"V Cavalca","year":"2001","unstructured":"Cavalca V, Cighetti G, Bamonti F, et al. Oxidative stress and homocysteine in coronary artery disease. [Clin Chem. 2001;47(5):887\u201392.","journal-title":"[Clin Chem"},{"issue":"3","key":"2354_CR35","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.jhep.2016.05.013","volume":"65","author":"G Targher","year":"2016","unstructured":"Targher G, Byrne CD, Lonardo A, et al. Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: a meta-analysis[. J Hepatol. 2016;65(3):589\u2013600.","journal-title":"J Hepatol"},{"key":"2354_CR36","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.ejogrb.2016.08.011","volume":"205","author":"S Behboudi-Gandevani","year":"2016","unstructured":"Behboudi-Gandevani S, Ramezani Tehrani F, Cheraghi L, et al. Could a body shape index and waist to height ratio predict insulin resistance and metabolic syndrome in polycystic ovary syndrome?[. Eur J Obstet Gynecol Reprod Biol. 2016;205:110\u20134.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2354_CR37","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.diabres.2018.07.029","volume":"147","author":"X Hou","year":"2019","unstructured":"Hou X, Chen S, Hu G, et al. Stronger associations of waist circumference and waist-to-height ratio with diabetes than BMI in Chinese adults[. Diabetes Res Clin Pract. 2019;147:9\u201318.","journal-title":"Diabetes Res Clin Pract"},{"key":"2354_CR38","doi-asserted-by":"publisher","first-page":"951689","DOI":"10.3389\/fendo.2022.951689","volume":"13","author":"Y Xue","year":"2022","unstructured":"Xue Y, Xu J, Li M, et al. Potential screening indicators for early diagnosis of NAFLD\/MAFLD and liver fibrosis: triglyceride glucose index-related parameters. [Front Endocrinol (Lausanne). 2022;13:951689.","journal-title":"[Front Endocrinol (Lausanne)"},{"issue":"3","key":"2354_CR39","doi-asserted-by":"publisher","first-page":"e0212963","DOI":"10.1371\/journal.pone.0212963","volume":"14","author":"J Lim","year":"2019","unstructured":"Lim J, Kim J, Koo SH, et al. Comparison of triglyceride glucose index, and related parameters to predict insulin resistance in Korean adults: an analysis of the 2007\u20132010 Korean National Health and Nutrition Examination Survey[. PLoS ONE. 2019;14(3):e0212963.","journal-title":"PLoS ONE"},{"key":"2354_CR40","doi-asserted-by":"crossref","unstructured":"Jeji PS, Mishra D, Shukla M et al. Comparison of Triglyceride-glucose Index (TyG index) and FIB-4 for Assessing Fibrosis in NAFLD[Journal of Clinical and Experimental Hepatology 2023;13.","DOI":"10.1016\/j.jceh.2023.07.173"},{"key":"2354_CR41","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.jpeds.2021.11.042","volume":"242","author":"K Song","year":"2022","unstructured":"Song K, Park G, Lee HS, et al. Comparison of the triglyceride glucose index and modified triglyceride glucose indices to predict nonalcoholic fatty liver disease in Youths[. J Pediatr. 2022;242:79\u2013e8571.","journal-title":"J Pediatr"},{"key":"2354_CR42","doi-asserted-by":"crossref","unstructured":"Song K, Lee HW, Choi HS et al. Comparison of the modified TyG indices and other parameters to Predict non-alcoholic fatty liver Disease in Youth[Biology. (Basel). 2022;11(5).","DOI":"10.3390\/biology11050685"},{"key":"2354_CR43","doi-asserted-by":"publisher","first-page":"102531","DOI":"10.1016\/j.ctim.2020.102531","volume":"53","author":"M Shahavandi","year":"2020","unstructured":"Shahavandi M, Djafari F, Shahinfar H, et al. The association of plant-based dietary patterns with visceral adiposity, lipid accumulation product, and triglyceride-glucose index in Iranian adults[. Complement Ther Med. 2020;53:102531.","journal-title":"Complement Ther Med"},{"issue":"10","key":"2354_CR44","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.1016\/j.numecd.2021.06.019","volume":"31","author":"A Wang","year":"2021","unstructured":"Wang A, Tian X, Zuo Y, et al. Association between the triglyceride-glucose index and carotid plaque stability in nondiabetic adults[. Nutr Metab Cardiovasc Dis. 2021;31(10):2921\u20138.","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"2354_CR45","doi-asserted-by":"publisher","first-page":"110199","DOI":"10.1016\/j.diabres.2022.110199","volume":"195","author":"H Wang","year":"2023","unstructured":"Wang H, He S, Wang J, et al. Hyperinsulinemia and plasma glucose level independently associated with all-cause and cardiovascular mortality in Chinese people without diabetes-A post-hoc analysis of the 30-year follow-up of Da Qing diabetes and IGT study[. Diabetes Res Clin Pract. 2023;195:110199.","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"2354_CR46","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1186\/s12933-022-01658-7","volume":"21","author":"X Li","year":"2022","unstructured":"Li X, Chan JSK, Guan B, et al. Triglyceride-glucose index and the risk of heart failure: evidence from two large cohorts and a mendelian randomization analysis. [Cardiovasc Diabetol. 2022;21(1):229.","journal-title":"[Cardiovasc Diabetol"},{"key":"2354_CR47","doi-asserted-by":"publisher","first-page":"994329","DOI":"10.3389\/fcvm.2022.994329","volume":"9","author":"H Qu","year":"2022","unstructured":"Qu H, Long LZ, Chen L, et al. Triglyceride-glucose index and estimated 10-year risk of a first hard cardiovascular event[. Front Cardiovasc Med. 2022;9:994329.","journal-title":"Front Cardiovasc Med"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-024-02354-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-024-02354-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-024-02354-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T12:04:43Z","timestamp":1721304283000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-024-02354-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,18]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2354"],"URL":"https:\/\/doi.org\/10.1186\/s12933-024-02354-4","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,18]]},"assertion":[{"value":"2 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"NHANES was conducted with approval by the National Center for Health Statistics Ethics Review Board, and obtained informed written consent from all the individuals involved in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"262"}}